ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,268,457 | -20.4% | 207,165 | -3.8% | 0.00% | 0.0% |
| Q2 2023 | $2,851,460 | -64.4% | 215,367 | -63.4% | 0.00% | -50.0% |
| Q1 2023 | $8,010,314 | -32.6% | 588,561 | -3.3% | 0.00% | -33.3% |
| Q4 2022 | $11,885,957 | +14.4% | 608,600 | +11.6% | 0.00% | 0.0% |
| Q3 2022 | $10,386,000 | -0.5% | 545,179 | +7.6% | 0.00% | 0.0% |
| Q2 2022 | $10,437,000 | +159.4% | 506,630 | +305.2% | 0.00% | +200.0% |
| Q1 2022 | $4,024,000 | +84.0% | 125,023 | +166.2% | 0.00% | 0.0% |
| Q4 2021 | $2,187,000 | +946.4% | 46,967 | +506.5% | 0.00% | – |
| Q3 2021 | $209,000 | – | 7,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |